Sleep Apnea Diagnostic System Market Predicted to reach US$600 Million by 2026
NEW YORK, April 24, 2017 /PRNewswire/ --
Highlights
-High obesity rate makes North America's sleep apnea diagnostic market more lucrative than other regional markets
-Sleep Apnea Diagnostic System Market is predicted to reach a value of more than US$600 Million.
- Over a forecast period 2016-2026
- At a CAGR of 7.3%.
North America is highly projected to dominate the regional market through 2016.
- It is predicted to grow by registering a CAGR of 7.4%
- Within 2016-2026.
-Another competitive region is Western Europe where projections shows a steady growing market in terms of revenue in the whole market segment.
- At a CAGR of 7.5% within the predicted period.
-Such growth in North America is sluggish because of;
- the high rate of adoption of sleep services
- Increasing obesity rates and prevalent haphazard lifestyles.
-Another contribution in North America is presence of new devices and easy regulation in the approval process when compared to other market segments.
In terms of revenue, the global sleep apnea diagnostic system market is projected to expand at a CAGR of 7.3% over the forecast period and is expected to be valued more than US$ 600 Mn by the end of 2026.
Obesity and rapidly rising aging population play a crucial role in the growth of the global sleep apnea diagnostic system market
Robust growth of wearable sleep apnea diagnostic devices is expected in the near future due to rise in adoption of home sleep testing services. Rising prevalence of obesity and rapidly ageing population in developed countries plays a crucial role in supporting growth of the market of sleep apnea diagnostic systems market. Introduction of novel technologies such as wireless screening devices and cloud based recording system are driving growth of the sleep services market. This in turn is expected to create a favourable environment for the global sleep apnea diagnostic system market over the forecast period.
Obstructive sleep apnea is a common form of sleep apnea disorder across the world
Sleep disorders are highly prevailing in majority of regions globally and is affecting the population health severely. Troublesome ill effects of the disorder are important cause for increase in rate of adoption for sleep apnea diagnostic systems. Sleep apnea is a chronic disorder that can be bifurcated in two different types- obstructive sleep apnea (OSA) and central sleep apnea. Among the two, obstructive sleep apnea is a common form of sleep apnea and around 3% – 4% of the population is affected.
Polysomnography segment will be able to achieve moderate growth in the forecast period
Although actigraphy monitoring devices of product type segment is expected to be the fastest growing segment over the forecast period, in terms of revenue share, currently the polysomnography monitoring devices sub-segment of product type segment offers the highest contribution in the global sleep apnea diagnostic system market. Polysomnography devices segment holds the largest market opportunity, accounting for a market share of approximately 40%. However, the polysomnography segment is experiencing moderate growth due to its nature and availability as an ambulatory testing device in future.
Company share analysis of the global sleep apnea diagnostic system market
Global sleep apnea diagnostic system market is consolidated and the introduction of novel technologies such as wireless screening devices and cloud based recording systems are driving growth of the global sleep services market. This in turn is expected to create a favourable environment for the global sleep apnea diagnostic system market over the forecast period. In 2015, Koninklijke Philips N.V., ResMed Inc., Becton, Dickinson and Company, Natus Medical Incorporated, MGC Diagnostics Corporation were the top five players dominating the global sleep apnea diagnostic system market contributing to around 83% of the total market share of sleep apnea diagnostic systems. In 2015, Koninklijke Philips N.V. dominated the market with around 38% market share of the global sleep apnea diagnostic system market followed by ResMED Inc. Koninklijke Philips N.V. has a strong foothold in the domestic market of North America, particularly in the rapidly growing respiratory and sleep disorder devices market.
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article